154 related articles for article (PubMed ID: 17163404)
1. Expression of the serine protease, matriptase, in breast ductal carcinoma of Chinese women: correlation with clinicopathological parameters.
Jin JS; Cheng TF; Tsai WC; Sheu LF; Chiang H; Yu CP
Histol Histopathol; 2007 Mar; 22(3):305-9. PubMed ID: 17163404
[TBL] [Abstract][Full Text] [Related]
2. Matriptase and survivin expression associated with tumor progression and malignant potential in breast cancer of Chinese women: tissue microarray analysis of immunostaining scores with clinicopathological parameters.
Tsai WC; Chu CH; Yu CP; Sheu LF; Chen A; Chiang H; Jin JS
Dis Markers; 2008; 24(2):89-99. PubMed ID: 18219094
[TBL] [Abstract][Full Text] [Related]
3. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
Oliveira VM; Piato S; Silva MA
Breast Cancer Res Treat; 2006 Feb; 95(3):235-41. PubMed ID: 16322898
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of Nek2 and β-catenin in breast carcinoma: clinicopathological correlations.
Wang S; Li W; Lv S; Wang Y; Liu Z; Zhang J; Liu T; Niu Y
Histopathology; 2011 Oct; 59(4):631-42. PubMed ID: 22014044
[TBL] [Abstract][Full Text] [Related]
5. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
6. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
7. [Aromatase expression in invasive and in situ ductal carcinoma present in the same breast].
Oliveira VM; Ribeiro Lde S; Rossi LM; Silva MA; Aldrighi JM; Bagnoli F; Rinaldi JF; Aoki T
Rev Assoc Med Bras (1992); 2009; 55(6):651-5. PubMed ID: 20191218
[TBL] [Abstract][Full Text] [Related]
8. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
El Sharkawy SL; Farrag AR
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
[TBL] [Abstract][Full Text] [Related]
9. N-Acetylglucosaminyltransferase III (GnT-III) but not N-Acetylgalactosaminyltransferase-6 and 8 are Differentially Expressed in Invasive and In Situ Ductal Carcinoma of the Breast.
da Silva Filho AF; Vieira-de-Mello GS; Dos Santos PB; de Melo Rêgo MJB; Ribeiro-Silva A; Beltrão EIC
Pathol Oncol Res; 2019 Apr; 25(2):759-768. PubMed ID: 30689164
[TBL] [Abstract][Full Text] [Related]
10. The clinicopathological significance of neurogenesis in breast cancer.
Zhao Q; Yang Y; Liang X; Du G; Liu L; Lu L; Dong J; Han H; Zhang G
BMC Cancer; 2014 Jul; 14():484. PubMed ID: 24996968
[TBL] [Abstract][Full Text] [Related]
11. Expression of aromatase and estrogen sulfotransferase in preinvasive and invasive breast cancer.
Hudelist G; Wülfing P; Kersting C; Burger H; Mattsson B; Czerwenka K; Kubista E; Gschwantler-Kaulich D; Fink-Retter A; Singer CF
J Cancer Res Clin Oncol; 2008 Jan; 134(1):67-73. PubMed ID: 17661084
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the pattern of cathepsin-D expression in fibroadenoma, fibrocystic disease, preinvasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 1999 Aug; 31(3):247-51. PubMed ID: 10503271
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 and human epidermal growth factor receptor type 2 (HER-2) expression simultaneously in invasive and in situ breast ductal carcinoma.
Lucarelli AP; Martins MM; Montor W; Oliveira V; Galvão MA; Piato S
Sao Paulo Med J; 2011 Dec; 129(6):371-9. PubMed ID: 22249792
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in ductal carcinoma in situ of the breast.
Shpitz B; Zimlichman S; Zemer R; Bomstein Y; Zehavi T; Liverant S; Bernehim J; Kaufman Z; Klein E; Shapira Y; Klein A
Breast Cancer Res Treat; 1999 Nov; 58(1):65-9. PubMed ID: 10634519
[TBL] [Abstract][Full Text] [Related]
15. [Expression of neuronal marker protein gene product 9.5 and its clinicopathologic significance in breast cancer].
Liu L; Zhao Q; Liang X; Du G; Lu L; Dong J; Han H
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):318-20. PubMed ID: 25030864
[TBL] [Abstract][Full Text] [Related]
16. Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool.
dos-Santos PB; Zanetti JS; Vieira-de-Mello GS; Rêgo MB; Ribeiro-Silva A A; Beltrão EI
Int J Clin Exp Pathol; 2014; 7(5):2337-49. PubMed ID: 24966944
[TBL] [Abstract][Full Text] [Related]
17. Loss of FAT1 during the progression from DCIS to IDC and predict poor clinical outcome in breast cancer.
Wang L; Lyu S; Wang S; Shen H; Niu F; Liu X; Liu J; Niu Y
Exp Mol Pathol; 2016 Feb; 100(1):177-83. PubMed ID: 26721716
[TBL] [Abstract][Full Text] [Related]
18. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
Rahko E; Kauppila S; Pääkkö P; Blanco G; Apaja-Sarkkinen M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Jukkola A
Tumour Biol; 2009; 30(5-6):257-64. PubMed ID: 19887890
[TBL] [Abstract][Full Text] [Related]
20. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
